aspirin and aspalatone

aspirin has been researched along with aspalatone in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (71.43)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, BH; Kang, YH; Kim, YC; Park, YH; Suh, DY; Yang, HO1
Han, BH; Kim, YC; Suh, DY; Yang, HO1
Choi, DY; Choi, JH; Jhoo, WK; Kim, C; Kim, HC; Nam, SW; Park, ES1
Han, BH; Kang, YH; Suh, DY1
Choi, DY; Jhoo, WK; Kim, C; Kim, HC; Koo, CH; Lee, DW1
Chun, IK; Gwak, HS1
Pal, PB; Ramana, KV; Shukla, K; Sonowal, H1

Other Studies

7 other study(ies) available for aspirin and aspalatone

ArticleYear
Synthesis and antiplatelet effects of the new antithrombotic agent aspalatone with low ulcerogenicity.
    Arzneimittel-Forschung, 1994, Volume: 44, Issue:10

    Topics: Adenosine Diphosphate; Animals; Antioxidants; Aspirin; Bleeding Time; Collagen; Fibrinolytic Agents; In Vitro Techniques; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Stomach Ulcer

1994
Metabolic fate of the new antithrombotic agent aspalatone in rats. In vivo and in vitro study.
    Arzneimittel-Forschung, 1995, Volume: 45, Issue:10

    Topics: Animals; Aspirin; Biotransformation; Chromatography, High Pressure Liquid; Dealkylation; Esterases; Fibrinolytic Agents; Humans; In Vitro Techniques; Male; Platelet Aggregation Inhibitors; Prodrugs; Rats; Rats, Sprague-Dawley; Salicylates; Spectrophotometry, Ultraviolet

1995
A new antithrombotic agent, aspalatone, attenuated cardiotoxicity induced by doxorubicin in the mouse; possible involvement of antioxidant mechanism.
    Life sciences, 1997, Volume: 60, Issue:4-5

    Topics: Animals; Antibiotics, Antineoplastic; Aspirin; Body Weight; Doxorubicin; Fibrinolytic Agents; Glutathione Peroxidase; Heart; Male; Mice; Mice, Inbred ICR; Myocardium; Oxidative Stress; Pyrones; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vitamin E

1997
Salicylate levels in rat stomach tissues after administration of aspalatone and acetylsalicylic acid in relation to their ulcerogenicity.
    Arzneimittel-Forschung, 1997, Volume: 47, Issue:7

    Topics: Animals; Aspirin; Gastric Mucosa; Male; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Salicylates; Stomach Ulcer

1997
Aspalatone, a new antiplatelet agent, attenuates the neurotoxicity induced by kainic acid in the rat.
    Life sciences, 1997, Volume: 61, Issue:24

    Topics: Animals; Aspirin; Brain; Kainic Acid; Lipid Peroxidation; Male; Neuroprotective Agents; Oxidative Stress; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley

1997
Effect of vehicles and enhancers on the in vitro skin penetration of aspalatone and its enzymatic degradation across rat skins.
    Archives of pharmacal research, 2001, Volume: 24, Issue:6

    Topics: Animals; Aspirin; Fibrinolytic Agents; Linoleic Acid; Male; Mice; Mice, Hairless; Pharmaceutical Vehicles; Rats; Rats, Sprague-Dawley; Skin; Skin Absorption; Species Specificity

2001
Aspalatone Prevents VEGF-Induced Lipid Peroxidation, Migration, Tube Formation, and Dysfunction of Human Aortic Endothelial Cells.
    Oxidative medicine and cellular longevity, 2017, Volume: 2017

    Topics: Antioxidants; Aorta; Apoptosis; Aspirin; Blotting, Western; Cell Adhesion; Cell Movement; Cell Proliferation; Cells, Cultured; Endothelium, Vascular; Humans; Lipid Peroxidation; Monocytes; Signal Transduction; Vascular Endothelial Growth Factor A

2017